The COPENHAGEN Puberty Study
NCT01411527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1957
Last updated 2019-10-10
Summary
By clinical examinations and withdrawing of blood samples from a large number of healthy Danish children, this study will reveal if age of pubertal onset is declining. Furthermore, the extensive normative data will provide detailed insight into normal ranges and individual changes of anthropometrics and hormone levels in healthy children during childhood and adolescence.
Conditions
- Puberty
Sponsors & Collaborators
-
The Ministry of Science, Technology and Innovation, Denmark
collaborator OTHER_GOV - collaborator OTHER
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Anders Juul, PhD, DMSc · Rigshospitalet, dept. of Growth and Reproduction
Eligibility
- Min Age
- 5 Years
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
NCT01419249 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
NCT02920515 ·Status: COMPLETED ·Phase: PHASE4
-
Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
NCT01196156 ·Status: COMPLETED
-
Use of Somatropin in Turner Syndrome
NCT01518036 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study on Treatment Compliance by Children Treated With Growth Hormone
NCT01068639 ·Status: WITHDRAWN
-
IGF1 Generation Test
NCT00145457 ·Status: COMPLETED ·Phase: PHASE4
-
BELux Children OutcoME During A(@)Dulthood With GHD
NCT06694506 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants
NCT02427958 ·Status: COMPLETED ·Phase: PHASE4
-
Endocrine Studies of Healthy Children
NCT00001195 ·Status: COMPLETED
-
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
NCT02790112 ·Status: UNKNOWN ·Phase: NA
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment
NCT01797718 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
NCT00191165 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
NCT00705172 ·Status: COMPLETED
-
Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
NCT01679925 ·Status: COMPLETED
-
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Long-term Somatropin Treatment in Children
NCT01543867 ·Status: COMPLETED
-
Efficacy on Height in SGA Children Treated With Growth Hormone
NCT00184756 ·Status: COMPLETED ·Phase: PHASE3
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years
NCT00184691 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
NCT00909844 ·Status: COMPLETED ·Phase: PHASE3
-
The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons
NCT00969644 ·Status: UNKNOWN ·Phase: NA
-
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
NCT03435627 ·Status: COMPLETED
-
Drug Use Investigation of Somatropin for GHD-ADULTS.
NCT00601419 ·Status: COMPLETED